These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26469113)

  • 21. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1472-3. PubMed ID: 20796140
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
    Zarski JP; Sturm N; Guechot J; Paris A; Zafrani ES; Asselah T; Boisson RC; Bosson JL; Guyader D; Renversez JC; Bronowicki JP; Gelineau MC; Tran A; Trocme C; De Ledinghen V; Lasnier E; Poujol-Robert A; Ziegler F; Bourliere M; Voitot H; Larrey D; Rosenthal-Allieri MA; Fouchard Hubert I; Bailly F; Vaubourdolle M;
    J Hepatol; 2012 Jan; 56(1):55-62. PubMed ID: 21781944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis C and liver fibrosis.
    Sebastiani G; Gkouvatsos K; Pantopoulos K
    World J Gastroenterol; 2014 Aug; 20(32):11033-53. PubMed ID: 25170193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viscoelasticity-based magnetic resonance elastography for the assessment of liver fibrosis in hepatitis C patients after liver transplantation.
    Kamphues C; Klatt D; Bova R; Yahyazadeh A; Bahra M; Braun J; Klauschen F; Neuhaus P; Sack I; Asbach P
    Rofo; 2012 Nov; 184(11):1013-9. PubMed ID: 22893489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.
    Boursier J; Bertrais S; Oberti F; Gallois Y; Fouchard-Hubert I; Rousselet MC; Zarski JP; Calès P
    BMC Gastroenterol; 2011 Nov; 11():132. PubMed ID: 22129438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
    Pár A; Pár G
    Orv Hetil; 2010 Nov; 151(47):1951-5. PubMed ID: 21071307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage of liver fibrosis in patients with congenital bleeding disorders and infected with hepatitis C virus.
    Kucharska M; Zaleska-Dorobisz U; Szymczak A; Inglot M; Rymer W; Zalewska M; Małyszczak K; Kuliszkiewicz-Janus M; Inglot M
    Pol Arch Intern Med; 2017 Jun; 127(6):412-417. PubMed ID: 28530647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of non-invasive markers and FibroScan values during HCV treatment.
    Vergniol J; Foucher J; Castéra L; Bernard PH; Tournan R; Terrebonne E; Chanteloup E; Merrouche W; Couzigou P; de Lédinghen V
    J Viral Hepat; 2009 Feb; 16(2):132-40. PubMed ID: 19175875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis.
    Tatsumi C; Kudo M; Ueshima K; Kitai S; Ishikawa E; Yada N; Hagiwara S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Kato M; Tonomura A; Mitake T; Shiina T
    Intervirology; 2010; 53(1):76-81. PubMed ID: 20068346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.
    Zarski JP; Sturm N; Guechot J; Zafrani ES; Vaubourdolle M; Thoret S; Margier J; David-Tchouda S; Bosson JL
    PLoS One; 2013; 8(3):e59088. PubMed ID: 23555619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The APRI and the RVR.
    Snyder N; Petersen JR
    J Clin Gastroenterol; 2009; 43(5):500-1. PubMed ID: 19098684
    [No Abstract]   [Full Text] [Related]  

  • 37. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
    Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
    Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.